Copyright newsweek
A man collapsed behind President Donald Trump during an Oval Office press conference on Thursday with drugmakers to expand coverage and reduce prices for popular obesity treatments Zepbound and Wegovy. Officials rushed to help him after his collapse, and the press was quickly removed. It was unclear what caused the collapse. White House press secretary Karoline Leavitt said in a statement, “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.” Newsweek has reached out to the White House for additional comment via email and filled out a contact request form with Novo Nordisk on Thursday. Medical emergency in Oval as Trump admin health officials were announcing a deal on lower prices for weight loss drugs. pic.twitter.com/lzzqdoEeE7— Jennifer Jacobs (@JenniferJJacobs) November 6, 2025 This is a breaking news story. Updates to follow. Correction: Novo Nordisk executive Gordon Findlay was originally identified by members of the working press as the person who collapsed. Novo Nordisk told Newsweek in a statement, “CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.” Commerce Secretary Howard Lutnick, from left, President Donald Trump, David Moore, president of Novo Nordisk Inc., Novo Nordisk President and CEO Mike Doustdar and Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, look on after a person collapsed during an event about drug prices, Thursday, Nov. 6, 2025, in the Oval Office of the White House in Washington. (AP Photo/Evan Vucci)
